Functional and Phenotypical Impairment of Polymorphonuclear Cells in Atopic Dermatitis: An Additional Cause for the Known Susceptibility to Infections?
Maria Teresa Fierro(University of Turin), Annamaria Cuffini(University of Turin), Mauro Novelli(University of Turin), Valeria Allizond(Department of Public Health), Pietro Quaglino(Department of Medical Sciences), Narcisa Mandras(University of Turin), Federica Marenco(University Dermatology), Pierangela Murabito(University of Turin), Giuliana Banche(University of Turin), Maria Grazia Bernengo(University of Turin), Chiara Merlino(University of Turin)
Cited by 12
Related Papers
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomas
|Journal of the American Academy of Dermatology|2002|493
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
|JAMA Dermatology|2015|452